Revenue
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Lifeward Ltd. (LFWD)
Price$6.98Cached quote
Net income
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.4M | $1.7M | $435,000 | $352,000 | $432,000 | $330,000 | $4.9M | $668,000 | $135,000 | $5.9M | $3.7M | $4.0M | $1.6M | $972,000 |
| Gross profit | $8.4M | $8.2M | $4.5M | $1.9M | $2.9M | $2.2M | $2.7M | $2.8M | $3.1M | $736,000 | $214,000 | −$621,000 | −$429,000 | −$11,000 |
| Gross margin | 602.00% | 483.29% | 1,023.68% | 541.19% | 671.99% | 663.33% | 55.94% | 422.90% | 2,297.04% | 12.54% | 5.71% | −15.72% | −27.02% | −1.13% |
| Research & development | $3.2M | $4.6M | $4.1M | $4.0M | $2.9M | $3.5M | $5.3M | $7.3M | $6.0M | $9.0M | $5.9M | $8.6M | $2.5M | $1.8M |
| Operating expenses | $28.1M | $37.6M | $28.1M | $21.0M | $15.6M | $14.2M | $16.8M | $22.0M | $25.1M | $31.2M | $25.4M | $19.3M | $8.3M | $5.7M |
| Operating income | −$19.7M | −$29.3M | −$23.6M | −$19.1M | −$12.7M | −$12.0M | −$14.0M | −$19.2M | −$22.0M | −$30.4M | −$25.2M | −$19.9M | −$8.7M | −$5.8M |
| Operating margin | −1,405.29% | −1,726.29% | −5,428.05% | −5,426.70% | −2,929.40% | −3,637.58% | −288.28% | −2,876.35% | −16,290.37% | −518.67% | −672.02% | −504.30% | −550.69% | −592.49% |
| EBITDA | −$19.3M | −$25.5M | −$21.8M | −$18.9M | −$12.4M | −$11.7M | −$13.7M | −$18.8M | −$21.4M | −$29.7M | −$24.7M | −$19.8M | −$8.7M | −$5.7M |
| EBITDA margin | −1,381.50% | −1,500.35% | −5,003.45% | −5,369.32% | −2,867.82% | −3,551.21% | −281.70% | −2,807.04% | −15,814.81% | −506.82% | −660.33% | −501.49% | −544.90% | −586.21% |
| Net income | −$19.9M | −$28.9M | −$22.1M | −$19.6M | −$12.7M | −$13.0M | −$15.6M | −$21.7M | −$24.7M | −$32.5M | −$25.4M | −$21.7M | −$12.2M | −$6.7M |
| Net profit margin | −1,422.43% | −1,702.47% | −5,088.05% | −5,559.38% | −2,948.15% | −3,932.12% | −319.13% | −3,244.76% | −18,308.89% | −553.81% | −678.46% | −548.42% | −766.81% | −684.98% |
| Basic EPSper basic share | -$17.16 | -$39.96 | -$31.13 | -$26.40 | -$22.68 | -$68.88 | -$226.80 | -$1,236.48 | -$2,567.88 | -$5,187.00 | -$4,410.00 | -$13,314.00 | -$156,513.00 | -$4,813.67 |
| Diluted EPSper diluted share | -$17.16 | -$39.96 | -$31.13 | -$26.40 | -$22.68 | -$68.88 | -$226.80 | -$1,236.48 | -$2,567.88 | -$5,187.00 | -$4,410.00 | -$13,314.00 | -$156,513.00 | -$4,813.67 |
Owners
Reported shareholders
≈44.21%of listed shares
ORAMED PHARMACEUTICALS INC.1.25M shares · Mar 25, 2026
View holders
| Holder | % owned |
|---|---|
ORAMED PHARMACEUTICALS INC. | ≈44.21%1.25M shares |
Lind Global Fund II LP | ≈30.34%858K shares |
Turk Joseph E Jr | ≈3.71%104.97K shares |
Swinford Michael | ≈3.57%100.96K shares |
Jasinski Lawrence J | ≈3.57%100.87K shares |
Lynch Jeannine | ≈3.40%96.07K shares |
Richner Randel | ≈2.03%57.49K shares |
PODUSKA JOHN WILLIAM SR | —55.95K shares |
Levy Hadar | —51.58K shares |
Marshall Robert J. Jr. | ≈1.27%35.92K shares |
CITADEL ADVISORS LLC | 0.64%18.06K shares |
Rose Keith Dale | ≈0.60%17.08K shares |
Rozenbaum Moshe H | ≈0.41%11.49K shares |
Sigsbee William Mark | ≈0.41%11.49K shares |
RENAISSANCE TECHNOLOGIES LLC | 0.40%11.33K shares |
KIDRON NADAV | ≈0.27%7.66K shares |
Kidron Miriam | ≈0.27%7.66K shares |
Reznick Yehuda | ≈0.27%7.66K shares |
UBS Group AG | 0.08%2.15K shares |
MORGAN STANLEY | <0.01%274 shares |
Percentages use 2.83M shares of this listed class outstanding on Jun 30, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 3 ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Sep 2, 2025Form 4 | Lynch JeannineVP of Market Access & Strategy | SellOrdinary Shares, par value NIS 1.75 per share · indirect | 1.6K | $0.64 | $1.0K | 46.1K |
| May 21, 2025Form 4 | Jasinski Lawrence JChief Executive Officer | SellOrdinary Shares, par value NIS 1.75 per share · indirect | 1.9K | $1.26 | $2.4K | 98.7K |
| Jan 7, 2025Form 4 | Lind Global Fund II LPTenPercentOwner | SellOrdinary Shares, par value NIS 1.75 per share · indirect | 700 | $2.69 | $1.9K | 858.0K |
| Jan 7, 2025Form 4 | Lind Global Fund II LPTenPercentOwner | SellOrdinary Shares, par value NIS 1.75 per share · indirect | 190.7K | $1.94 | $370.0K | 858.7K |
| Jan 6, 2025Form 4 | Lind Global Fund II LPTenPercentOwner | SellOrdinary Shares, par value NIS 1.75 per share · indirect | 298.4K | $3.46 | $1.03M | 1.05M |